Abstract Fibroblast growth factor receptors (Fgfrs) are expressed in the ureteric bud and metanephric mesenchyme of the developing kidney. Furthermore, in vitro and in vivo studies have shown that exogenous fibroblast growth factors (Fgfs) increase growth and maturation of the metanephric mesenchyme and ureteric bud. Deletion of fgf7, fgf10, and fgfr2IIIb (the receptor isoform that binds Fgf7 and Fgf10) in mice lead to smaller kidneys with fewer collecting ducts and nephrons. Overexpression of a dominant negative receptor isoform in transgenic mice has revealed more striking defects including renal aplasia or severe dysplasia. Moreover, deletion of many fgf ligands and receptors in mice results in early embryonic lethality, making it difficult to determine their roles in kidney development. Recently, conditional targeting approaches revealed that deletion of fgf8 from the metanephric mesenchyme interrupts nephron formation. Furthermore, deletion of fgfr2 from the ureteric bud resulted in both ureteric bud branching and stromal mesenchymal patterning defects. Deletion of both fgfr1 and fgfr2 in the metanephric mesenchyme resulted in renal aplasia, characterized by defects in metanephric mesenchyme formation and initial ureteric bud elongation and branching. Thus, Fgfr signaling is critical for growth and patterning of all renal lineages at early and later stages of kidney development.
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Background on kidney development and fibroblast growth factor receptors
The metanephric kidney develops from two tissues arising from the intermediate mesoderm, the nephric duct and the nephrogenic cord [1] . Around embryonic day 10.5 (E10.5) in the mouse and the fifth week of gestation in humans, the nephrogenic cord gives rise to paired densities of cells in the region of the hind limb called the metanephric mesenchyme [1] . The mesenchyme in turn induces a single evagination from the nephric duct called the ureteric bud that elongates and contacts the mesenchyme [1] . Once the tissues come into contact, they begin a series of reciprocal inductive interactions [1] . The ureteric bud receives signals to branch mostly dichotomously (see Fig. 1 ), eventually maturing into collecting tubules and ducts, the pelvis, and the ureter [1] . At each terminal tip, the ureteric bud induces adjacent areas of metanephric mesenchyme to form condensates, followed by epithelial vesicles, comma shaped bodies, S-shaped bodies, and finally mature nephron epithelium (see Fig. 1 ) [1] . The maturing nephrons, arising first in juxtamedullary cortex, ultimately fuse with the maturing collecting tubules at the connecting segment [1] . Regions of metanephric mesenchyme surrounding the nephrogenic mesenchyme and ureteric bud tree are called the stromal mesenchyme and likely differentiate into renal interstitial cells and the muscle surrounding the ureter [2] .
In humans, kidney development is completed between the 32-36 weeks of gestation, while in the mouse it continues until about 10 days after birth [1] .
Fibroblast growth factor receptors are a gene family of receptor tyrosine kinases with at least four signaling members [3] . Three of these genes (fgfrs1-3) are capable of producing multiple receptor isoforms through alternative splicing of primary transcripts [3] . These receptors are activated by binding to Fgf ligands, of which there are 22 known family members in mammals [3] . Structurally, the receptors consist of up to three external immunoglobulin (Ig)-like domains, a transmembrane domain, and an intracellular kinase domain (see Fig. 2 ) [3] . The diversity in intracellular portions of some receptor isoforms may mediate different biological responses after binding to the same ligand [3] . In addition, alternate splicing of the Cterminal portion of the third Ig-like domain results in IIIb or IIIc isoforms, which have different ligand binding specificities (see Fig. 2 ) [3] . Despite the large numbers of receptors and receptor isoforms, all Fgfrs associate with the same three adapter molecules to transmit intracellular signaling and have conservation of their intracellular adapter binding sites [3] . In vitro, Fgfr activation is associated with many biological responses including proliferation, differentiation, migration, and inhibition of apoptosis [4] . Finally, fibroblast growth factor receptors are expressed in many tissues of the developing embryo starting prior to implantation and often persisting into adulthood [3] .
Fgfr expression in the developing kidney
While Fgfr3 and Fgfr4 have been detected in embryonic kidneys [5] [6] [7] , most studies have focused on Fgfr1 and Fgfr2 expression in the developing kidney. Early publications reported strong fgfr1 mRNA signal in undifferentiated metanephric mesenchyme, condensing mesenchyme, and developing nephrons in mouse embryos examined at E12.5 through E16.5 [8, 9] . In contrast, fgfr2 mRNA was found principally throughout the ureteric bud tree in mouse embryos examined at the same ages [8, 9] . An later analysis in rat kidneys from E15.5 through E20 reported Fgfr1 mRNA and protein expression not only in renal mesenchymal tissues, but also in ureteric bud tips [5] . Conversely, while Fgfr2 protein was found primarily throughout the ureteric bud tree, it was also present in maturing glomeruli and nephron tubules [5] . In agreement with the latter findings, our laboratory not only detected strong fgfr2 mRNA expression in ureteric bud tissues in E13.5 mice, but also fgfr2 mRNA transcripts in mesenchymal-derived tissues including developing nephrons and stromal cells around the ureteric bud [10] . Fgfr expression earlier than E12.5 was first described by whole mount in situ hybridization in murine renal explants harvested at E11.5 and grown in culture for 2 days; fgfr1 expression was principally in peripheral stromal mesenchyme and fgfr2 signal was in ureteric bud epithelium and surrounding condensing mesenchyme [11] . Our laboratory recently examined expression in intact E10.5 and E11.5 mouse embryos by in situ hybridization. We detected strong fgfr1 expression in early metanephric mesenchyme and less intense signal in the initial ureteric bud at both ages. Fgfr2 was present in early metanephric mesenchyme, ureteric bud, and nephric duct at low levels at E10.5, and increased in intensity at all tissues by E11.5 [12] . Thus, although both receptors are expressed in each renal lineage, it appears that Fgfr1 is expressed most strongly in metanephric mesenchymal tissues and Fgfr2 in the ureteric bud, especially in older embryos.
Response of the developing renal lineages to exogenous Fgfs
Several reports have shown that exogenous fibroblast growth factors (Fgfs) increase growth and maturation of the metanephric mesenchyme and ureteric bud tissues. An early report demonstrated that addition of Fgf2 (which was produced by cultured ureteric bud cells) and Fgf4 to undifferentiated E13.0 rat metanephric mesenchymal tissues in culture stimulated cell growth and prevented apoptosis [13] . Other investigators showed that Fgf2 was not only capable of rescuing isolated rat metanephric mesenchymal tissues, but also induced mesenchymal condensation, based on histological changes and marker expression [14] . In combination with other growth factors such as transforming growth factor β or transforming growth factor α and leukemia inhibitory factor, Fgf2 was even capable of inducing complete conversion of rat metanephric mesenchymal tissues into nephron epithelium in culture [15, 16] . In Xenopus, Fgf2 in combination with retinoic acid was capable of differentiating explanted pronephric mesoderm into a glomerulus [17] . In addition to effects on mesenchymal lineages, Fgf2 and other ligands including Fgf1, Fgf7, and Fgf10 stimulated growth and differentially affected branching morphogenesis in isolated rat ureteric bud cultures [18] . Furthermore, addition of Fgf7 to intact rat embryonic kidney explants increased ureteric bud growth and consequently the number of nephrons compared with untreated controls [19] . Finally, a transgenic mouse with overexpression of human Fgf7 directed to the liver developed high serum levels of the ligand; this resulted in hyperplasia and cystic dilation of cortical and medullary collecting ducts [20] . Thus, addition or overexpression of different fibroblast growth factors in vitro and in vivo increases growth and maturation of both mesenchymal and ureteric bud lineages in the developing kidney.
Effects of targeted fgf deletion on the developing kidney
Although exogenous Fgfs alter growth of metanephric mesenchymal and/or ureteric bud tissues, it was not clear which ligands were functionally relevant in vivo until mouse knockouts were generated. The first targeted deletion of a ligand showing an abnormal renal phenotype was of fgf7 [19] . Fgf7 is produced by stromal mesenchyme around the ureteric bud and binds with a high degree of specificity to the Fgfr2IIIb isoform which is expressed in the ureteric bud [19] . Although fgf7 null mice are viable, they have a reduction in ureteric bud branch numbers and about 30% fewer nephrons (likely secondary to the reduction in ureteric bud tips) (see Table 1 ) [19] . Deletion fgf10, another ligand with specificity for Fgfr2IIIb, resulted in perinatal lethality likely secondary to severe dysgenesis/ agenesis of many organs including lungs and limbs [21] . Although not described in detail, the fgf10 null mice had a renal phenotype similar to the fgf7 knockouts, with smaller kidneys and fewer collecting ducts (see Table 1 ) [21] .
A limitation to determining the roles of many other Fgfs in the developing kidney has been early embryonic lethality in the knockout mice. Fgf8, for example, is expressed throughout the early metanephric mesenchyme and later in developing nephrons; however, fgf8 null mice die at the time of gastrulation, prior to the onset of renal development [22, 23] . To circumvent the early lethality of the fgf8 knockout mice and determine the role of the ligand in the embryonic kidney, two groups of investigators recently used a cre recombinase-lox p conditional knockout approach (see Fig. 3 ). By breeding floxed fgf8 mice with Pax3cre transgenic mice (that express cre recombinase in the metanephric mesenchyme) or Tcre transgenic mice (that express cre in all mesodermal tissues), each group generated conditional knockouts with no functional fgf8 in Mes-/-mice survived until birth, but they had small kidneys with an interruption in nephron formation after the epithelial vesicle stage (see Table 1 and Fig. 4 ) [22, 23] . Thus, Fgfr signaling is critical for nephron formation.
Effects of genetic blockade of Fgfr signaling on the developing kidney
The first mouse with altered fgfr expression that had renal abnormalities was a transgenic line carrying a solubilized Fgfr2IIIb fragment, which acted as a dominant negative by binding many different Fgfs (and thus preventing much of the signaling through all of the endogenous Fgfrs) [24] . The mutant embryos developed severe renal dysgenesis or agenesis (as well as severe lung, exocrine and endocrine gland, cutaneous, and limb anomalies) [24] . Thus, it was clear that Fgfr signaling was critical for early stages of kidney development. As is the case with many fgf ligands, however, traditional gene targeting methods for the fgfrs have been of limited value with one exception. Deletion of the fgfr2IIIb isoform (the receptor for both Fgf7 and Fgf10) results in a renal phenotype similar to the fgf7 and fgf10 knockouts, including smaller kidneys with fewer nephrons than normal [25] (see Table 1 ). However, deletion of all fgfr2 isoforms results in early embryonic lethality, prior to the onset of renal development [26, 27] . Similarly, fgfr1 null mice die during or shortly after gastrulation, before the kidney starts to form [28, 29] . Mice with deletion of fgfr3 or fgfr4 alone or in combination are viable and have no obvious kidney abnormalities ( [30, 31] and unpublished data, 2004), making these receptors unlikely candidates to mediate important signaling in the developing kidney. Thus, although the transgenic dominant negative mouse suggested additional roles for Fgfrs in kidney development, traditional targeting of the fgfr1 and fgfr2 were of limited value due to early embryonic lethality.
To circumvent the early embryonic lethality of the fgfr1 and fgfr2 mice, our laboratory has used conditional knockout strategies in the ureteric bud and the metanephric mesenchyme. For the ureteric bud studies, we bred Hoxb7creGFP transgenic mice (expressing cre recombinase and a green fluorescent protein in the ureteric bud tree) with floxed fgfr1/fgfr2 mice [10] . Mice with deletion of fgfr1, fgfr2, or fgfr1/2 in the ureteric bud (fgfr UB-/-) were viable and reproduce. However, both the fgfr2 UB-/-and the fgfr1/ 2 UB-/-mice had smaller and often abnormally shaped kidneys compared with than their littermates throughout embryogenesis and into young adulthood (the fgfr2 UB-/-and the fgfr1/2 UB-/-kidneys are indistinguishable). In the fgfr2 mutants, ureteric bud tree branching was abnormal with long slender trunks and fewer and smaller ampullae (see Fig. 5 ). Nephron formation occurred normally in fgfr2 UB-/-mutants, although compared with controls there were approximately 30% fewer, likely secondary to the decrease in ureteric bud tip number. Strikingly, cortical stromal mesenchymal patterning was disrupted with aberrant subcapsular thickening (see Fig. 5 ) and excessive apoptosis in fgfr2 UB-/-mutants. It is not clear if all of the abnormalities in the fgfr2 UB-/-mice are through mediated through the Fgfr2IIIb isoform alone; while the fgfr2IIIb isoform knockout mice do have smaller kidneys and fewer nephrons, there has not been a rigorous analysis of ureteric bud tree or stromal mesenchymal patterning [25] . Interestingly, the combined ureteric bud tree and stromal patterning abnormalities in fgfr2 UB-/-mice are very similar to mice with blockade of stromal vitamin A signaling [32] and mice with deletion of the Ret9 isoform [33] . Despite an apparent signaling loop between vitamin A and Ret in the kidney [34] , there has not yet been an association detected between Fgfr2 signaling and the aforementioned molecules. Thus, In the presence of the cre recombinase enzyme, the lox p sites recombine, removing the critical gene region, deactivating the gene. If a floxed mouse is bred with a transgenic mouse expressing cre recombinase only in the kidney, the gene will be deactivated in the kidney but will be intact elsewhere in the mouse Fgfr2 signaling in the ureteric bud is critical for ureteric bud and stromal mesenchyme patterning.
To determine the role(s) of fgfr1 and/or fgfr2 in the metanephric mesenchyme, we bred floxed fgfr1/fgfr2 mice with Pax3cre transgenic mice (as was used in one of the fgf8 conditional knockout studies [22] ). While deletion of either individual allele (fgfr1 Mes-/-or fgfr2 Mes-/-) does not appear to significantly affect kidney development, mice with deletion of both alleles (fgfr1/2
Mes-/-) developed complete renal agenesis [12] , reminiscent of the transgenic dominant negative receptor mice [24] . The fgfr1/2
Mes-/-mice do develop a ureteric bud (and occasionally an ectopic bud), but it does not elongate or branch (see Fig. 6 ). Furthermore, the compound mutant mice do not develop an obvious metanephric mesenchyme by hematoxylin and eosin (H & E) staining (see Fig. 6 ). By in situ hybridization, the fgfr1/2
Mes-/-embyros do express markers of metanephric mesenchyme such as Eya1, Six1, and Wt1 (Wilm's Tumor antigen) in a restricted domain near the ureteric bud, but not other markers such as Six2, Sall1, or Pax2. The ureteric bud appears to express normal markers; however, glial cell line derived neurotrophic factor (Gdnf), a ligand secreted by the metanephric mesenchyme leading to ureteric bud growth and branching, is only present at E10.5 and absent at E11.5. Therefore, the ureteric bud is able to initiate at E10.5, but cannot elongate or branch by E11.5. Thus, Fgfr1 and Fgfr2 signaling (together) in the metanephric mesenchyme are critical for formation of the metanephric mesenchyme and early development of the ureteric bud.
Furthermore, although deletion of fgfr1 or fgfr2 from the mesenchyme alone does not affect the kidney proper, careful analysis of the fgfr2
Mes-/-mice has revealed anterior ectopic ureteric buds with failure of the normal posterior ureteric bud to branch about 50% of the time (CB, unpublished data). Thus Fgfr2 signaling in the metanephric mesenchyme may also be critical for normal induction sites of the ureteric bud.
Conclusion
In conclusion, many fibroblast growth factors and all of their receptors are expressed in the developing kidney. In vitro and in vivo studies have shown that exogenous Mes-/-mice (b) appear to possess initial ureteric buds (arrowheads) but no obvious metanephric mesenchyme c-f Whole mount in situ hybridization for ret shows that at E11.0, both control (c) and fgfr1/ 2
Mes-/-(d) embryos develop initial ureteric bud evaginations (arrowheads) from the nephric duct (nd). By E11.5, the control ureteric bud has elongated and branched forming an initial trunk and ampulla (e), whereas the fgfr1/2
Mes-/-ureteric bud fails to elongate or branch (f) although occasionally 2 initial ureteric buds are present (asterisk=re-gion of nephric duct that attaches to the cloaca) (a,b=200× magnification; c-f=25× magnification). [Reprinted from Fig. in [12] with permission from Elsevier] fibroblast growth factors affect both renal mesenchymal and ureteric bud development. Follow up transgenic and gene knockout strategies have shown that fibroblast growth factor receptor signaling is required for patterning of all renal lineages, including the ureteric bud, nephrogenic mesenchyme, and stromal mesenchyme. Furthermore, Fgfr activity is critical at early stages as well as later stages of kidney development. Of all of the receptors, Fgfr2 appears to be the most important in the context of kidney development. In humans, activating mutations of FGFR2 cause Apert's syndrome, Antley-Bixler syndrome, and Beare-Stevenson syndrome, which are sometimes associated with urogenital anomalies such as hydroureter and solitary kidney [35] [36] [37] . Taken together, perturbations in fibroblast growth factor receptor signaling many be responsible for many cases of human renal hypoplasia/ dysplasia/aplasia.
